Categorical predictive and disease progression modeling in the early stage of Alzheimer’s disease is a research paper published in Journal of Neuroscience Methods (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01 AG024904
F. Hoffmann-La Roche
IXICO
National Institute of Biomedical Imaging and Bioengineering
Alzheimer's Association
Takeda Pharmaceutical Company
Alzheimer's Drug Discovery Foundation
Johnson and Johnson
Merck
GE Healthcare
Innogenetics
Medpace
Alzheimer's Disease Neuroimaging Initiative
National Institute on Aging
Genentech
Janssen Research and Development
FWCI
0.99
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Longitudinal survival analysis and two-group comparison for predicting the progression of mild cognitive impairment to Alzheimer's disease
Longitudinal survival analysis and two-group comparison for predicting the progression of mild cognitive impairment to Alzheimer's disease